AFL · 8-K · 20260806PR054333
Product Launch and Transition
AFLAC INC · 2026-08-06 · Importance 51 · Surprise 50 · In source text
Aflac Japan reported new opportunities from Anshin Palette medical insurance, Miraito cancer insurance, and Tsumitasu life insurance. Second-quarter new annualized premium sales declined 5.6% to ¥19.6 billion ($123 million), primarily because Miraito faced a high comparison following its March 2025 launch. Growth in refreshed Tsumitasu savings-type life insurance and Anshin Palette, launched in December 2025, partially offset the decline. First-half sales increased 7.0% to ¥37.3 billion ($235 million).
Key facts
- Anshin Palette (medical insurance) was launched in December 2025 and is cited as a new product securing opportunities in Japan. source
- Aflac Japan attributed a 3.7% decline in net earned premiums in yen to a new external reinsurance transaction for WAYS and Tsumitasu and limited pay products reaching paid-up status. source
- Miraito cancer insurance was launched in March 2025 and had a high prior-year sales baseline that contributed to a year-over-year sales decline in the quarter. source
- Tsumitasu savings-type life insurance is referenced as refreshed and contributed strong growth to offset Miraito's sales baseline. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Anshin Palette (medical insurance) was launched in December 2025 and is cited as a new product securing opportunities in Japan. |